Episode 64 of Tech Buzz China is the second of two episodes on the Chinese telemedicine sector, which is closely watched in the wake of COVID-19. This week, on the heels of episode 63โs discussion of Ping An Good Doctor, co-hosts Rui Ma and Ying-Ying Lu talk about other experiments, such as Chunyu Yisheng ๆฅ้จๅป็, WeDoctor ๅฅฝๅคงๅคซ, and Dingxiangyuan ไธ้ฆๅญ. We also give overviews of telemedicine efforts by some of the large internet companies, including Alibaba, Baidu, and JD Health.
The overarching story is that healthcare tech is a clear market opportunity in China, and within the narrow space of telemedicine, there are a lot of companies trying to solve the same set of problems. Listen to find out: How did these players all converge on telemedicine, and what are the factors โ some currently missing โ that must be in place to drive a serious uptick in adoption?
You can find these stories and more atย pandaily.com. If you enjoy our content, please do let us know by leaving us an iTunes review, and tweeting at us atย @techbuzzchina. We also read your emails, atย rui@techbuzzchina.comย andย ying@techbuzzchina.com. You can also subscribe to ourย Extra Buzzย newsletter on our new website,ย techbuzzchina.com. As always, thank you for your support.
We are grateful for our talented producers, Caiwei Chen and Kaiser Kuo. Stay healthy, everyone!
